KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors.

S V Liu, R Dziadziuszko, S Viteri, F Cappuzzo, S Comis, V Gabarre, C Chevalier, T Vandewalle, F Montestruc, B Vasseur, J Remon, B Besse

Lung Cancer 203 108516

PMID40174385
PMCID-
DOI10.1016/j.lungcan.2025.108516
发表日期2025-04-02
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。